Advertisement
IQV vs MTD
Which Stock Would AI Choose? IQVIA Holdings (IQV) vs. Mettler-Toledo International (MTD) Stock Comparison
Key Takeaways
- IQV trades at a more attractive forward price-to-earnings (P/E) ratio of 12.36 compared to MTD's 27.17, indicating potential undervaluation.
- Recent quarterly revenue growth stands higher for IQV at 10.3% year-over-year (YoY) versus MTD's 8.1% YoY.
- MTD boasts superior profitability with a 21.59% profit margin, exceeding IQV's 8.34%.
- Market capitalizations are closely matched around $26 billion for both stocks.
- IQV has delivered stronger year-to-date (YTD) gains of about 29%, though recent weeks show pullback amid market volatility.
- Both face upcoming first-quarter 2026 earnings reports, potentially driving near-term momentum.
Introduction
This stock comparison pits IQV, a leader in clinical research and healthcare analytics, against MTD, a precision instruments provider serving life sciences labs. Both operate in the interconnected healthcare ecosystem, supporting pharmaceutical innovation and research. Investors and traders eyeing defensive growth in biotech and medtech sectors may find value here, as the duo highlights trade-offs between service-driven scalability and hardware reliability amid evolving market dynamics like AI integration and lab demand. This analysis dissects their recent trajectories for informed relative performance insights.
IQV Overview and Recent Performance
IQV, or IQVIA Holdings Inc., delivers advanced analytics, technology solutions, and contract research services to life sciences firms globally across segments like Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. In recent market activity, IQV shares have experienced a pullback, trading around $160 after a 52-week high near $247. This follows a strong fourth-quarter 2025 earnings beat with 10.3% revenue growth and adjusted EPS up 9.6%, yet sentiment softened due to AI-related concerns despite the launch of IQVIA.ai with NVIDIA. Broader healthcare trends and anticipation for first-quarter 2026 results on May 5 have influenced volatility, with analysts maintaining an Outperform rating and $230 average target.
MTD Overview and Recent Performance
MTD, or Mettler-Toledo International Inc., specializes in precision instruments including laboratory balances, pipetting solutions, and industrial scales for pharmaceutical, biotech, and food sectors across U.S., Swiss, and other operations. Shares hover near $1,258 within a 52-week range of $1,052 to $1,525, reflecting steady performance with YTD gains around 10%. Recent weeks show resilience amid mixed revenue signals, buoyed by strong profitability and analyst Overweight views targeting $1,488. Upcoming first-quarter 2026 earnings on May 7 underscore lab equipment demand stability, though slower growth versus peers has tempered enthusiasm in recent market positioning.
Trending AI Robots
Tickeron’s Trending AI Robots page curates 25 top-performing bots from over 350 AI trading bots that cover thousands of tickers across diverse strategies like momentum, trend following with fundamental analysis, and volatility plays on ETFs. These bots showcase impressive stats tailored to current market conditions: annualized returns from 23% to 162%, win rates of 51% to 88%, profit factors up to 3.33+, and profit-to-drawdown ratios reaching 17. Timeframes span 5-minute to 60-minute charts, with average trade durations from hours to weeks. This elite selection highlights bots excelling in sectors like semiconductors and small caps. Explore Trending AI Robots to align automated strategies with today’s volatility.
Head-to-Head Comparison
IQV’s service-oriented model emphasizes scalable R&D and data analytics, contrasting MTD’s tangible precision instruments reliant on hardware sales and recurring services. Growth drivers favor IQV with faster recent revenue and EPS expansion (17.6% YoY quarterly earnings growth), while MTD excels in margins and ROA (20.35%). Recent momentum shows IQV more volatile (beta 1.18) with YTD outperformance but pullbacks, versus MTD’s steadier path (beta 1.31). Risks include IQV’s high debt-to-equity (246%) and MTD’s premium valuation. Both tap life sciences exposure, but IQV leans clinical trials, MTD lab tools. Market sentiment tilts positive for both via analyst upgrades.
Tickeron AI Verdict
Tickeron’s AI currently favors IQV over MTD, driven by compelling forward valuation, accelerated growth trends, and substantial upside to analyst targets amid stabilizing catalysts like earnings. While MTD offers margin strength, IQV’s relative positioning suggests higher probability of outperformance in the near term.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IQV is a Buy and MTD is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IQV’s FA Score shows that 0 FA rating(s) are green whileMTD’s FA Score has 1 green FA rating(s).
- IQV’s FA Score: 0 green, 5 red.
- MTD’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IQV’s TA Score shows that 6 TA indicator(s) are bullish while MTD’s TA Score has 5 bullish TA indicator(s).
- IQV’s TA Score: 6 bullish, 3 bearish.
- MTD’s TA Score: 5 bullish, 5 bearish.
Price Growth
IQV (@Medical Specialties) experienced а +7.84% price change this week, while MTD (@Medical Specialties) price change was -14.44% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +0.85%. For the same industry, the average monthly price growth was +2.49%, and the average quarterly price growth was -7.30%.
Reported Earning Dates
IQV is expected to report earnings on Jul 28, 2026.
MTD is expected to report earnings on Jul 23, 2026.
Industries' Descriptions
@Medical Specialties (+0.85% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| IQV | MTD | IQV / MTD | |
| Capitalization | 29B | 21.8B | 133% |
| EBITDA | 3.52B | 1.24B | 283% |
| Gain YTD | -23.007 | -22.641 | 102% |
| P/E Ratio | 21.56 | 25.34 | 85% |
| Revenue | 16.6B | 4.03B | 412% |
| Total Cash | 2.1B | 66.9M | 3,143% |
| Total Debt | 16.1B | 2.15B | 748% |
IQV | MTD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 17 | 51 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 67 Overvalued | 99 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 42 | 3 | |
PRICE GROWTH RATING 1..100 | 57 | 64 | |
P/E GROWTH RATING 1..100 | 47 | 66 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IQV's Valuation (67) in the Servicestothe Health Industry industry is in the same range as MTD (99) in the Medical Specialties industry. This means that IQV’s stock grew similarly to MTD’s over the last 12 months.
IQV's Profit vs Risk Rating (100) in the Servicestothe Health Industry industry is in the same range as MTD (100) in the Medical Specialties industry. This means that IQV’s stock grew similarly to MTD’s over the last 12 months.
MTD's SMR Rating (3) in the Medical Specialties industry is somewhat better than the same rating for IQV (42) in the Servicestothe Health Industry industry. This means that MTD’s stock grew somewhat faster than IQV’s over the last 12 months.
IQV's Price Growth Rating (57) in the Servicestothe Health Industry industry is in the same range as MTD (64) in the Medical Specialties industry. This means that IQV’s stock grew similarly to MTD’s over the last 12 months.
IQV's P/E Growth Rating (47) in the Servicestothe Health Industry industry is in the same range as MTD (66) in the Medical Specialties industry. This means that IQV’s stock grew similarly to MTD’s over the last 12 months.
| IQV | MTD | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 67% |
| Stochastic ODDS (%) | 2 days ago 66% | 2 days ago 55% |
| Momentum ODDS (%) | 2 days ago 66% | 2 days ago 60% |
| MACD ODDS (%) | 2 days ago 58% | 2 days ago 69% |
| TrendWeek ODDS (%) | 2 days ago 60% | 2 days ago 63% |
| TrendMonth ODDS (%) | 2 days ago 62% | 2 days ago 66% |
| Advances ODDS (%) | 5 days ago 58% | 7 days ago 63% |
| Declines ODDS (%) | 14 days ago 63% | 2 days ago 63% |
| BollingerBands ODDS (%) | 2 days ago 80% | 2 days ago 74% |
| Aroon ODDS (%) | 2 days ago 44% | 2 days ago 63% |
Advertisement
MTD and
Correlation & Price change
A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.
| Ticker / NAME | Correlation To MTD | 1D Price Change % | ||
|---|---|---|---|---|
| MTD | 100% | -4.08% | ||
| A - MTD | 76% Closely correlated | -3.60% | ||
| RVTY - MTD | 73% Closely correlated | -2.03% | ||
| TMO - MTD | 70% Closely correlated | -2.67% | ||
| DHR - MTD | 68% Closely correlated | -2.71% | ||
| BRKR - MTD | 67% Closely correlated | -2.02% | ||
More | ||||